DGAP-News: Biotest AG
/ Key word(s): Miscellaneous
Biotest AG opens 11th plasma collection centre in Czech Republic
Dreieich, 9 June 2022. Biotest has received the operating license for its eleventh plasma collection centre in Czech Republic from the country's national public health authority SUKL.
The centre in Mladá Boleslav is located in the Central Bohemian Region north-east of Prague. About 45,000 people live there. In the state-of-the-art centre with 15 donor beds, plasma donors can donate plasma six days a week, from Monday to Saturday. Thanks to this new plasma centre, twelve new qualified jobs will be created in Mladá Boleslav.
Biotest is thus continuing the planned expansion of its own donor centres in Europe in order to significantly increase its plasma collection capacity.
"The opening of the centre in Mladá Boleslav is another milestone on our way to expand the plasma collection volume and increase Biotest AG's self-supply rate. We would like to express our sincere thanks to our dedicated team as well as to the current and future donors for their tireless commitment to the care of patients worldwide," emphasises Henrik Oehme, Vice President of Plasma Service Europe GmbH.
The collected plasma is processed exclusively at Biotest AG in Dreieich. Audits conducted regularly in the Czech Republic ensure that the high legal and internal quality and safety requirements are met.
About human blood plasma
Ordinary shares: securities’ ID No. 522720; ISIN DE0005227201
09.06.2022 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
|Phone:||0 61 03 - 8 01-0|
|Fax:||0 61 03 - 8 01-150|
|Listed:||Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange|
|EQS News ID:||1371047|
|End of News||DGAP News Service|